Skip to main content

Isopto Cetamide Side Effects

Generic name: sulfacetamide sodium ophthalmic

Medically reviewed by Drugs.com. Last updated on Jul 20, 2023.

Note: This document contains side effect information about sulfacetamide sodium ophthalmic. Some dosage forms listed on this page may not apply to the brand name Isopto Cetamide.

Applies to sulfacetamide sodium ophthalmic: ophthalmic ointment, ophthalmic solution, ophthalmic suspension.

Side effects include:

Local irritation, transient stinging or burning.

For Healthcare Professionals

Applies to sulfacetamide sodium ophthalmic: ophthalmic ointment, ophthalmic solution.

General

The side effects reported most often were local/conjunctival irritation, stinging, and burning.[Ref]

Ocular

Frequency not reported: Local/conjunctival irritation, stinging, burning, nonspecific conjunctivitis, conjunctival hyperemia, bacterial corneal ulcers, fungal corneal ulcers[Ref]

Hypersensitivity

Rare (less than 0.1%): Sensitivity reactions

Frequency not reported: Allergic reactions/hypersensitivity, local hypersensitivity progressing to fatal syndrome resembling systemic lupus erythematosus (SLE)[Ref]

At least 1 case of local hypersensitivity has been reported that progressed to a SLE-like fatal syndrome.[Ref]

Other

Frequency not reported: Secondary infections[Ref]

Dermatologic

Sulfonamides:

-Frequency not reported: Stevens-Johnson syndrome, toxic epidermal necrolysis[Ref]

Fatalities reported rarely due to severe reactions to sulfonamides (including toxic epidermal necrolysis, Stevens-Johnson syndrome, fulminant hepatic necrosis, aplastic anemia, agranulocytosis, other blood dyscrasias).

Stevens-Johnson syndrome was reported in a patient with history of blistering drug reaction to an oral sulfonamide.[Ref]

Hematologic

Sulfonamides:

-Frequency not reported: Agranulocytosis, aplastic anemia, other blood dyscrasias[Ref]

Fatalities reported rarely due to severe reactions to sulfonamides (including toxic epidermal necrolysis, Stevens-Johnson syndrome, fulminant hepatic necrosis, aplastic anemia, agranulocytosis, other blood dyscrasias).[Ref]

Hepatic

Fatalities reported rarely due to severe reactions to sulfonamides (including toxic epidermal necrolysis, Stevens-Johnson syndrome, fulminant hepatic necrosis, aplastic anemia, agranulocytosis, other blood dyscrasias).[Ref]

Sulfonamides:

-Frequency not reported: Fulminant hepatic necrosis[Ref]

References

1. Product Information. Sodium Sulamyd (sulfacetamide sodium ophthalmic). Schering Corporation. PROD.

2. Cerner Multum, Inc. Australian Product Information.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.